Belite Bio Inc ADR
Price & Volume
Stats
See more52W Range | $49-$86.53 |
Market Cap | $2.5B |
Shares Short | 197,932 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.55 |
News
See moreYahoo Finance • 28 days ago
Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease
Yahoo Finance • last month
Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors
Yahoo Finance • 2 months ago
Belite Bio Q2 2025 presentation: expenses rise as clinical trials advance
Yahoo Finance • 2 months ago
Belite Bio GAAP EPS of -$0.31 beats by $0.10
About
CEO | Dr. Yu-Hsin Lin M.B.A., Ph.D. |
CFO | Mr. Hao-Yuan Chuang C.F.A., F.R.M., M.B.A. |
Address | 12750 High Bluff Drive, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 25 |
